Clik here to view.
FDA Says Novalar Brochure for Dental Drug is Misleading
Denise Gellene [Updated 2/26/10, 1:30 pm. See below.] The FDA has told San Diego-based Novalar to stop using a misleading patient brochure promoting the company’s injectible dental drug, phentolamine...
View ArticleClik here to view.
Novalar Strikes Deal With Sanofi to Market Dental Drug in Germany, Maybe Rest...
Luke Timmerman Novalar has convinced one of the world’s biggest drugmakers, Paris-based Sanofi-Aventis, that it might be onto something. The San Diego-based biotech is announcing today that it has...
View ArticleClik here to view.
Small Deals Add Up: A Roundup of Under-the-Radar Deals in San Diego
Bruce V. Bigelow July was a busy month for small deals, according to the latest data from CB Insights, the New York information and data services firm that tracks the private company deals that help...
View ArticleClik here to view.
Now What? Novalar Sells Its Anesthesia Reversal Drug to Septodont
Bruce V. Bigelow In an unexpected development, San Diego’s Novalar Pharmaceuticals says today it has sold OraVerse, its dental anesthesia reversal agent and only FDA-approved product, to Lancaster,...
View ArticleClik here to view.
Novalar Plans Shutdown Following Sale of OraVerse to Septodont
Bruce V. Bigelow It turns out that Novalar Pharmaceuticals’ decision to sell OraVerse, its dental anesthesia reversal agent, was only half the story. Novalar CEO Donna Janson tells The San Diego...
View Article
